Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Matthew
Contact Matthew, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
The challenges for implementing Good Clinical Practices in the bioanalytical laboratory: a discussion paper from the European Bioanalysis Forum
Implementation of Good Clinical Practices (GCP) in the bioanalytical laboratory has been discussed within the European Bioanalysis Forum (EBF) for almost 15 years. Key drivers for this discussion were 1. EBF member companies based in the UK being inspected regularly by the Medicines and Healthcare products Regulatory Agency (MHRA) that combine GCP and Good Laboratory Practices (GLP) inspections 2.
Recommendations and feedback from the European Bioanalysis Forum Workshop: 1 year into ICH M10 – keeping our finger on the pulse | Bioanalysis
With the new ICH M10 guideline being adopted more than a year ago [1], the European Bioanalysis Forum (EBF) brought together the bioanalytical community in a workshop, “One Year into ICH M10 – Keeping Our Finger on the Pulse” to share and discuss how the guideline has been put into practice.
Finding our way in the In Vitro Diagnostic Medical Devices Regulation: a discussion paper from the European Bioanalysis Forum
The authors thank the EBF IVDR team for their input in the initial discussions: D Steinbüsch and E Schick, F Hoffmann - La Roche; M Richter, Abbvie; Philippe Ancian, Charles River Laboratories; Antje Lukas, Boehringer-Ingelheim; L Christodoulou, UCB Biopharma; Tracy Iles, Labcorp Drug Development; Claire Seal, F-star, an invoX company; Petra Struwe, Celerion; Lene Andersen, Lundbeck; Yang Liu, and Janet Waldron, Novartis; and Monika Köhnke, BioAgilytix.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Matthew
Contact Matthew, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack